相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia
Julian G. Rubino et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
How would we treat our own heparin-induced thrombocytopenia during cardiac surgery?
Andreas Koster et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2021)
Serotonin-release assay-negative heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Potential and Limitations of the New P2Y12Inhibitor, Cangrelor, in Preventing Heparin-Induced Platelet Aggregation During Cardiac Surgery: An In Vitro Study
Emmanuelle Scala et al.
ANESTHESIA AND ANALGESIA (2020)
Ticagrelor causes false-negative functional tests for heparin-induced thrombocytopenia
Julia J. M. Eekels et al.
BLOOD (2020)
Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia
Matteo Marchetti et al.
BLOOD (2020)
Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation
Ian Johnston et al.
BLOOD (2020)
The Year in Coagulation: Selected Highlights From 2019
Michael A. Mazzeffi et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2020)
Effectiveness of intravenous immunoglobulin use in heparin-induced thrombocytopenia
Madan R. Aryal et al.
BLOOD COAGULATION & FIBRINOLYSIS (2020)
Use of IV Immunoglobulin G in Heparin-Induced Thrombocytopenia Patients Is Not Associated With Increased Rates of Thrombosis A Population-Based Study
Binod Dhakal et al.
CHEST (2020)
Combination of two complementary automated rapid assays for diagnosis of heparin-induced thrombocytopenia (HIT)
Theodore E. Warkentin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Diagnosis and management of heparin-induced thrombocytopenia
Yves Gruel et al.
ANAESTHESIA CRITICAL CARE & PAIN MEDICINE (2020)
Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia
Brigitte Tardy et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Challenges in Detecting Clinically Relevant Heparin-Induced Thrombocytopenia Antibodies
Theodore E. Warkentin
HAMOSTASEOLOGIE (2020)
Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the Literature
Yves Gruel et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Therapeutic plasma exchange and intravenous immune globulin in the treatment ofheparin-inducedthrombocytopenia: A systematic review
Chinonso Onuoha et al.
TRANSFUSION (2020)
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland
Alberio A. Lorenzo et al.
SWISS MEDICAL WEEKLY (2020)
Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia
Claire Kizlik-Masson et al.
BLOOD (2019)
Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia
Jose Perdomo et al.
NATURE COMMUNICATIONS (2019)
Cardiac Surgery Successfully Managed With Cangrelor in a Patient With Persistent Anti-PF4/Heparin Antibodies 8 Years After Heparin-Induced Thrombocytopenia
Emmanuelle Scala et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2019)
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review
Theodore E. Warkentin
EXPERT REVIEW OF HEMATOLOGY (2019)
Plasma exchange for heparin-induced thrombocytopenia in patients on extracorporeal circuits: A challenging case and a survey of the field
Joseph H. Cho et al.
JOURNAL OF CLINICAL APHERESIS (2019)
The use of cangrelor with heparin for left ventricular assist device implantation in a patient with acute heparin-induced thrombocytopenia
Yan K. Gernhofer et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2018)
Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia
Theodore E. Warkentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT
Theodore E. Warkentin et al.
BLOOD (2018)
Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia
Allyson M. Pishko et al.
BLOOD ADVANCES (2018)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia
Adam Cuker et al.
BLOOD ADVANCES (2018)
Neutrophil accumulation and NET release contribute to thrombosis in HIT
Kandace Gollomp et al.
JCI INSIGHT (2018)
Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia
Vincent Hayes et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies
C. Kizlik-Masson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia
R. A. Raschke et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Autoimmune heparin-induced thrombocytopenia
A. Greinacher et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation
S. C. Jordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review
Dilli Ram Poudel et al.
PLATELETS (2017)
Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies
Caroline Vayne et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia
Anand Padmanabhan et al.
CHEST (2017)
Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia
Valerie Tutwiler et al.
BLOOD (2016)
Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis
Michael Nagler et al.
BLOOD (2016)
The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21)
Sanjay Khandelwal et al.
BLOOD (2016)
How I treat patients with a history of heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
BLOOD (2016)
A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis
Anand Padmanabhan et al.
CHEST (2016)
Diagnostic accuracy of rapid immunoassays for heparin-induced thrombocytopenia A systematic review and meta-analysis
Lova Sun et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin-induced thrombocytopenia-reactive antibodies or with true HIT (HIT-reactive antibodies plus thrombocytopenia): An 11-year experience
George Palatianos et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2
Jerome Rollin et al.
BLOOD (2015)
Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study
Lori-Ann Linkins et al.
BLOOD (2015)
Heparin-Induced Thrombocytopenia
Andreas Greinacher
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Polyphosphates form antigenic complexes with platelet factor 4 (PF4) and enhance PF4-binding to bacteria
Sven Brandt et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Scoring systems for heparin-induced thrombocytopenia (HIT): Whither now?
Theodore E. Warkentin
THROMBOSIS AND HAEMOSTASIS (2015)
Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities
Theodore E. Warkentin et al.
BLOOD (2015)
Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis
Anand Padmanabhan et al.
BLOOD (2015)
Plasmapheresis May Be an Option in Urgent Management of Heparin-Induced Thrombocytopenia in the Setting of Acute Intracerebral Hemorrhage
Emitseilu Iluonakhamhe et al.
NEUROCRITICAL CARE (2015)
Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder
Theodore E. Warkentin et al.
BLOOD (2014)
Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin
Theodore E. Warkentin et al.
BLOOD (2014)
Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4
Miriam E. Jaax et al.
BLOOD (2013)
PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI
Raj S. Kasthuri et al.
BLOOD (2012)
Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients
Vanessa Nellen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
A rare case of intracerebral hemorrhage complicating heparin-induced thrombocytopenia with thrombosis: a clinical dilemma ameliorated by novel use of plasmapheresis
Nay Min Tun et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
Platelet factor 4 binds to bacteria-inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia
Krystin Krauel et al.
BLOOD (2011)
Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis
T. E. Warkentin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Plasmapheresis and Heparin Reexposure as a Management Strategy for Cardiac Surgical Patients with Heparin-Induced Thrombocytopenia
Ian J. Welsby et al.
ANESTHESIA AND ANALGESIA (2010)
Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia
Lubica Rauova et al.
BLOOD (2010)
The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion
A. Cuker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery 'spontaneous' HIT
R. K. Pruthi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia
Theodore E. Warkentin et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantation
Sixten Selleng et al.
BLOOD (2008)
Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion
Zhihua Xiao et al.
BLOOD (2008)
Fatal heparin-induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of 'spontaneous' HIT?
R. M. Jay et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Heparin-induced thrombocytopenia - therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes
K. Krauel et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia
C. Pouplard et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Endothelial cell damage in heparin-induced thrombocytopenia
Simon J. Davidson et al.
BLOOD COAGULATION & FIBRINOLYSIS (2007)
Heparin-induced thrombocytopenia: An autoimmune disorder regulated through dynamic autoantigen assembly/disassembly
Douglas B. Cines et al.
JOURNAL OF CLINICAL APHERESIS (2007)
Guidelines on the use of intravenous immune globulin for hematologic conditions
David Anderson et al.
TRANSFUSION MEDICINE REVIEWS (2007)
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings
GK Lo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia
L Rauova et al.
BLOOD (2005)
The homozygous FcγRIIIa-158V genotype is a risk factor for heparin-induced thrombocytopenia in patients with antibodies to heparin platelet factor 4 complexes
Y Gruel et al.
BLOOD (2004)
Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin induced thrombocytopenia
AP Hong et al.
BLOOD (2003)
Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells
M Blank et al.
INTERNATIONAL IMMUNOLOGY (2002)
Simultaneous engagement of thrombin and FcγRIIA receptors results in platelets expressing high levels of procoagulant proteins
P Batar et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2001)
One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II
A Koster et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2001)
Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis
GP Visentin et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2001)
Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia
B Pötzsch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)